Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Syncytial giant-cell hepatitis--a specific disease entity?

J Y Lau1, G Koukoulis, G Mieli-Vergani

  • 1Institute of Liver Studies, King's College Hospital School of Medicine and Dentistry, London, United Kingdom.

Journal of Hepatology
|May 1, 1992
PubMed
Summary

Syncytial giant-cell hepatitis, previously linked to paramyxovirus, has diverse causes and does not always indicate a poor prognosis. Some patients, like those with autoimmune hepatitis, show improvement with treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laminin Immunostaining in Biopsies as a Useful Biomarker of Early Invasion in Actinic Cheilitis and Differential Diagnosis Between Actinic Cheilitis and Lip Cancer: New Insights.

Head and neck pathology·2022
Same author

Real-world management of juvenile autoimmune liver disease.

United European gastroenterology journal·2018
Same author

Smad4 and epithelial-mesenchymal transition proteins in colorectal carcinoma: an immunohistochemical study.

Journal of molecular histology·2018
Same author

Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.

Clinical and experimental immunology·2017
Same author

Autoimmune hepatitis: From mechanisms to therapy.

Revista clinica espanola·2016
Same author

Mutation profile of KRAS and BRAF genes in patients with colorectal cancer: association with morphological and prognostic criteria.

Genetics and molecular research : GMR·2015

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Syncytial giant-cell hepatitis was recently associated with paramyxovirus infection.
  • This condition was thought to carry a poor prognosis.

Purpose of the Study:

  • To review cases of syncytial giant-cell hepatitis.
  • To identify etiological factors and clinical outcomes.
  • To assess the prognosis of this liver condition.

Main Methods:

  • Retrospective review of twelve patients diagnosed with syncytial giant-cell hepatitis over 8.5 years.
  • Analysis of etiological causes, including autoimmune conditions, viral infections (Hepatitis A, B, C, Epstein-Barr virus), and primary sclerosing cholangitis.
  • Evaluation of treatment response, particularly corticosteroid therapy, and histological changes via liver biopsy.

Related Experiment Videos

Main Results:

  • Identifiable etiological causes were found in seven patients, including autoimmune chronic active hepatitis, primary sclerosing cholangitis, hepatitis A and B, Epstein-Barr virus, and hepatitis C virus.
  • One patient with autoimmune chronic active hepatitis responded well to corticosteroids, showing histological improvement.
  • Among the remaining five patients, three experienced fulminant hepatic failure, and two had severe chronic active hepatitis.

Conclusions:

  • Syncytial giant-cell hepatitis is likely multifactorial, not solely related to a single etiological agent.
  • The prognosis for syncytial giant-cell hepatitis is not uniformly poor and can vary based on the underlying cause and treatment response.